Trial Profile
Pharmacogenetic Study of Pioglitazone and Quetiapine XR Treatment Response in Mood Disorders
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Jul 2023
Price :
$35
*
At a glance
- Drugs Pioglitazone (Primary) ; Quetiapine (Primary)
- Indications Bipolar disorders; Major depressive disorder
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 08 Jul 2015 Status changed from recruiting to completed, as reported by ClinicalTrials.gov.
- 30 Apr 2011 New trial record